Le cluster Liver Neoplasms (radionuclide imaging) - Liver Neoplasms (secondary)
| 000170 (1999) | Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. | |
| 000286 (1989) | Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. | |
| 000175 (1998) | Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. | |
| 000176 (1998) | Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. | |
| 000193 (1997) | Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. | |
| 000199 (1996) | Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. | |
| 000207 (1996) | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. | |
| 000125 (2004) | Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. | |
| 000205 (1996) | Could somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)? | |
| 000213 (1995) | Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. | |
| 000228 (1994) | Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. | |
| 000241 (1993) | Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | |
| 000258 (1992) | Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. | |
| 000023 (2012) | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. | |
| 000058 (2009) | Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study. | |
| 000154 (2000) | Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. | |
| 000168 (1999) | Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. | |
| 000197 (1996) | Somatostatin receptor imaging in small cell lung cancer. | |
| 000200 (1996) | Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome. | |
| 000224 (1994) | Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. |
| This area was generated with Dilib version V0.5.76. |  |